Skip to content

Clinical observation of fospropofol disodium compounded with low-dose propofol in painless gastroenteroscopy in elderly patients

Clinical observation of fospropofol disodium compounded with low-dose propofol in painless gastroenteroscopy in elderly patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105408
Enrollment
Unknown
Registered
2025-07-03
Start date
2025-07-03
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Fospropofol disodium group (F):Fospropofol disodium group
Fospropofol disodium + propofol group (FP):Fospropofol disodium + propofol group

Sponsors

The First People’s Hospital of Jingzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Gender is not limited, age 65-80 years old; 2.BMI=19~28 kg /m2; 3.ASA class II or III; 4.Peration length <= 30 min; 5.Complete and accurate clinical data; 6.Patients and family members are fully aware of the process of this study, and are willing to sign the informed consent form and comply with the order in strict accordance with the requirements.

Exclusion criteria

Exclusion criteria: 1.Hypersensitivity to intravenous anesthetics or analgesics; 2.Psychiatric or neurological disorders; 3.Asthma exacerbation period; 4.Long-term application of narcotic sedative and analgesic medications; 5.Severe hepatic or renal impairment; 6.Difficult airway; 7.Recent history of upper respiratory tract infections; 8.History of alcohol or drug abuse; 9. Participated in other drug clinical trials as a subject in the past 3 months. 10. Patients who refused to participate in the study;

Design outcomes

Primary

MeasureTime frame
Sedation success;Onset of action;

Secondary

MeasureTime frame
Time to loss of eyelash reflex;HR at different time points;Postoperative adverse reaction stituation;Additional dose of propofol;RR at different time points;MAP at different time points;SpO2 at different time points;Time to awakening,;Narcotrend values at different time points;Time to discharge;

Countries

China

Contacts

Public ContactXia Rui

The First People’s Hospital of Jingzhou

879560350@qq.com+86 18972161338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026